Deal Provides Strategic Fit For Elanco, Lilly’s Animal Health Division
GREENFIELD, Ind. — Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products. The products, including vaccines, parasiticides and feed additives, are [...]

Collaboration with Susan G. Komen for the Cure® to Battle Breast Cancer and Support Life Science Researchers Throughout North America
CORNING, N.Y. – Corning Incorporated (NYSE: GLW) today announced the Corning Lab for the Cure™ program, a first-of-its-kind corporate sponsorship agreement with Susan G. Komen for the Cure®. Under terms of the agreement and through a [...]

Future of the Ocrelizumab RA clinical programme under evaluation
Roche and Biogen Idec announced today their decision to suspend Ocrelizumab treatment of patients in the Rheumatoid Arthritis (RA) programme. The decision follows the recommendation of the independent Ocrelizumab RA & Lupus Data and Safety Monitoring Board (DSMB) based on their assessment of the studies [...]

First-of-Its-Kind Project Will Sequence Difficult Breast Cancers to Provide Insight into Treatment Strategies
CARLSBAD, Calif., PHOENIX & THE WOODLANDS, Texas (BUSINESS WIRE) — LifeTechnologies Corporation (NASDAQ:LIFE) today announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose [...]

Miami, FL — Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010. Cumulative safety data for STELARA™ [...]

Abbott Park, Illinois (NYSE: ABT) and Watertown, Massachusetts — Abbott and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials. The trial will evaluate three HCV antiviral agents, including the investigational protease inhibitor ABT-450, part of the Abbott-Enanta collaboration, and polymerase inhibitors ABT-333 and ABT-072 currently being [...]

Vevey, Switzerland, March 2, 2010

Nestlé has concluded the acquisition of Kraft Foods’ frozen pizza business on 1 March 2010 after the completion of closing conditions. Consequently, the process of integrating Kraft Foods’ pizza business into the Nestlé Group will begin today as 3,620 Kraft Foods’ pizza employees, with their valuable talent and category expertise, will [...]

[...]

[...]

Press release distributed in partnership with …  
The RightThing Brings Together Over 100 [...]